ocular disease mRNA-based drug (CureVac/Schepens Eye Research Institute/Harvard Medical School)

N/A

Report date: 2025/01/26 16:26:18
NME

Base Information

Drug Nameocular disease mRNA-based drug (CureVac/Schepens Eye Research Institute/Harvard Medical School)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCureVac NV
China Registration ClassN/A

Develop Information

Active CompaniesCureVac NVHarvard Medical SchoolSchepens Eye Research Institute Inc
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A